GABA pharmacology--what prospects for the future?
1Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX13QT, UK. les.iversen@pharm.ox.ac.uk
Biochemical Pharmacology
|September 29, 2004
Summary
Researchers are advancing GABA pharmacology, developing new drugs targeting GABA uptake and receptors. This progress promises improved anti-anxiety, anticonvulsant, and hypnotic agents with fewer side effects.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Gamma-aminobutyric acid (GABA) is recognized as a key inhibitory neurotransmitter.
- Advances in understanding GABA uptake and receptor characterization have propelled GABA pharmacology.
- Existing GABAergic drugs can have sedative and dependence liabilities.
Purpose of the Study:
- To review progress in GABA pharmacology.
- To highlight potential for developing novel GABA uptake inhibitors.
- To explore new therapeutic agents targeting GABA-A receptors.
Main Methods:
- Review of scientific literature on GABA pharmacology.
- Analysis of current and emerging GABA uptake inhibitors.
- Examination of molecular pharmacology of GABA-A receptors.
Main Results:
- Tiagabide is a marketed GABA uptake inhibitor, with more selective agents in development.
- Understanding GABA-A receptor subtypes may yield improved anxiolytics and anticonvulsants.
- Gaboxadol (THIP) represents a novel non-benzodiazepine hypnotic acting on GABA-A receptors.
Conclusions:
- Further research into GABAergic mechanisms, including neurosteroid interactions, holds significant therapeutic promise.
- Development of selective GABA uptake inhibitors and novel GABA-A receptor modulators is ongoing.
- Future GABA pharmacology aims for enhanced efficacy and reduced adverse effects in neurological and psychiatric disorders.
More Related Videos
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...